Sinopharm Group Co. Ltd. (1099.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 54.56B |
| Enterprise Value | 101.6B |
| P/E Ratio | 6.35 |
| PEG Ratio | 4.79 |
| Price/Sales Ratio | 0.08 |
| Price/Book Ratio | 0.54 |
| Enterprise/Revenue | 0.16 |
| Enterprise/EBITDA | 4.54 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.03 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 575.17B |
| Revenue/Share | 183.86 |
| Gross Profit | 41.67B |
| EBITDA | 19.26B |
| Net Income | 7.16B |
| Diluted EPS | 2.29 |
Balance Sheet
| Total Cash | 61.59B |
| Total Cash/Share | 19.69 |
| Total Debt | 108.63B |
| Total Debt/Equity | 1.29 |
| Current Ratio | 1.41 |
| Book Value Per Share | 42.91 |
Price History
| 52-Week Change | -12.12 |
| 52-Week High | 22.34 |
| 52-Week Low | 15.28 |
| Moving Average 50 Days | 17.27 |
| Moving Average 200 Days | 19.5 |
Statistics
| Average Volume | 6.55M |
| Shares Outstanding | 3.12B |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.68 |
| Trailing Annual Dividend Yield | 4.7 |
| Payout Ratio | 0.59 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
